Transamerica Financial Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1502149
CEDAR RAPIDS, IA
Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$504,677
+$84,483 QoQ
Shares Held
1,016
+8.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,075
of 1,746 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $10,594,247 across 53 Biotechnology names. VRTX ranks #3 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
77,403 | $6,309,118 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,288 | $2,494,936 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,016 | $504,677 | |
| 4 | RPRX |
Royalty Pharma plc
|
6,380 | $357,726 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,673 | $254,257 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
1,789 | $155,553 | |
| 7 | ARGX |
Argenx SE
|
161 | $149,370 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
4,118 | $104,185 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,677 | 1,016 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $420,194 | 941 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,438,282 | 7,584 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,021,502 | 7,715 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,397,321 | 7,631 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,806,321 | 7,851 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,202,270 | 7,952 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,801,563 | 8,174 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $216,079 | 461 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $192,702 | 461 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,409,873 | 3,465 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,594,387 | 4,585 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,988,291 | 5,650 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,727,528 | 5,483 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,628,430 | 5,639 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,632,716 | 5,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,517,720 | 5,386 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $1,008 | 5 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||